BCL2L10 is a predictive factor for resistance to Azacitidine in MDS and AML patients
Thomas Cluzeau(Inserm), Patrick Auberger(Inserm)
Cited by 83
Related Papers
Mechanisms of AXL overexpression and function in Imatinib-resistant chronic myeloid leukemia cells
|Oncotarget|2011|119
Acadesine Kills Chronic Myelogenous Leukemia (CML) Cells through PKC-Dependent Induction of Autophagic Cell Death
|PLoS ONE|2009|80
All tyrosine kinase inhibitor-resistant chronic myelogenous cells are highly sensitive to Ponatinib
|Oncotarget|2012|34
The caspase 6 derived N-terminal fragment of DJ-1 promotes apoptosis via increased ROS production
|Cell Death and Differentiation|2012|20